These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 13002596)

  • 1. Treatment of headache with ergotamine-caffeine suppositories.
    MAGEE KR; WESTERBERT MR; DEJONG RM
    Neurology; 1952; 2(6):477-80. PubMed ID: 13002596
    [No Abstract]   [Full Text] [Related]  

  • 2. Cafergot suppositories in migraine.
    FUCHS M; BLUMENTHAL LS
    Ann Allergy; 1951; 9(5):616-20; passim. PubMed ID: 14878311
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of migraine; with special reference to ergotamine tartrate-caffeine rectal suppositories.
    ZANFAGNA PE
    Postgrad Med; 1952 May; 11(5):423-4. PubMed ID: 14920326
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of headache with cafergot].
    PICHLER E
    Wien Klin Wochenschr; 1955 Jun; 67(25):462-7. PubMed ID: 13247864
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe migraine with cafergot.
    CLAWSON TA
    Rocky Mt Med J; 1952 Dec; 49(12):1038-9. PubMed ID: 13014954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ergotamine-caffeine and dihydroergotamine-caffeine in migraine therapy].
    DALSGAARD-NIELSEN T
    Ugeskr Laeger; 1952 Aug; 114(34):1138-42. PubMed ID: 13015718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cafergot compound (suppositories) in therapy of migraine & Horton's syndrome].
    EKBOM KA
    Sven Lakartidn; 1957 May; 54(20):1619-24. PubMed ID: 13455501
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache.
    Ryan RE
    Headache; 1970 Jan; 9(4):212-20. PubMed ID: 4904954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ergotamine tartrate with caffeine in therapy of migraine attacks].
    DUBARRY JJ; DUBARRY E; BOUCHARENC G
    Arch Mal Appar Dig Mal Nutr; 1955 Mar; 44(3):399-400. PubMed ID: 14388859
    [No Abstract]   [Full Text] [Related]  

  • 10. Ergotamine tartrate and caffeine (EC 112) in migraine headaches.
    SWIRSKY MY
    Conn State Med J; 1954 Feb; 18(2):121-3. PubMed ID: 13127366
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rectal administration of ergotamine caffeine tartrate in the treatment of migraine].
    VAGUE J; FAVIER G; BERTHET J
    Sem Hop; 1957 Jun; 33(37):2358-9. PubMed ID: 13454899
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on headache; central versus peripheral action of ergotamine tartrate and its relevance to the therapy of migraine headache.
    GOODELL H; OSTFELD AM; PICHLER E; WOLFF HG
    AMA Arch Neurol Psychiatry; 1956 Dec; 76(6):571-7. PubMed ID: 13371972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of ergotamine tartrate-caffeine in migraine attacks (EC 110 cafergon); first results].
    GIRARD M
    Arch Mal Appar Dig Mal Nutr; 1950; 39(9-10):1016-21. PubMed ID: 14790963
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of migraine-like headaches with EC 112 suppositories.
    LINDERT MC
    Wis Med J; 1952 Sep; 51(9):874-5. PubMed ID: 13006356
    [No Abstract]   [Full Text] [Related]  

  • 15. [Favorable effect of ergotamine tartrate with caffeine on headache subsequent to gaseous electroencephalography].
    GERHARD JP; MAZOUE F
    Cah Psychiatr; 1956 May; (11):72-5. PubMed ID: 13342989
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of ergot-caffeine suppositories in migraine.
    BLUMENTHAL LS; FUCHS M
    Med Ann Dist Columbia; 1950 Feb; 19(2):77-9. PubMed ID: 15410166
    [No Abstract]   [Full Text] [Related]  

  • 17. Rectal use of ergotamine tartrate and caffeine alkaloid for the relief of migraine.
    GRAHAM JR
    N Engl J Med; 1954 Jun; 250(22):936-8. PubMed ID: 13165929
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of headache; Four new agents compared with Cafergot and E.C.B.-210.
    RYAN RE
    Mo Med; 1951 Feb; 48(2):106-08. PubMed ID: 14804070
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis and therapy of vascular cephalalgia].
    MAHNERT E
    Wien Med Wochenschr; 1956 Jan; 106(2):56-8. PubMed ID: 13300095
    [No Abstract]   [Full Text] [Related]  

  • 20. Ergotamine tolerance in patients with migraine.
    FRIEDMAN AP; VON STORCH TJ
    J Am Med Assoc; 1955 Mar; 157(11):881-4. PubMed ID: 13233043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.